# Filing Detail

Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001178913-24-002748
Filing Date
2024-08-23
Accepted
2024-08-23 16:08:08
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | F-3 | zk2431902.htm | F-3 | 448511
2 | EXHIBIT 5.2 | exhibit_5-1.htm | EX-5.1 | 11591
3 | EXHIBIT 23.1 | exhibit_23-1.htm | EX-23.1 | 2608
4 | EXHIBIT 107 | exhibit_107.htm | EX-FILING FEES | 29691
5 |  | image0.jpg | GRAPHIC | 224359
6 |  | image00001.jpg | GRAPHIC | 447436
| Complete submission text file | 0001178913-24-002748.txt |  | 1418910

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-281750 | Film No.: 241236366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)